Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-05-29 | Amended | $58,330,980 | $2,721,480 | Equity Only | 06b | SEC link |
| 2023-08-07 | Amended | $55,609,500 | $3,596,000 | Equity Only | 06b | SEC link |
| 2023-04-03 | Amended | $52,013,500 | $25,000 | Equity Only | 06b | SEC link |
| 2023-03-30 | Amended | $51,988,500 | $4,964,000 | Equity Only | 06b | SEC link |
| 2022-05-26 | New | $47,024,500 | $47,024,500 | Equity Only | 06b | SEC link |
| 2021-07-06 | Amended | $42,153,500 | Unknown | Equity Only | SEC link | |
| 2020-08-24 | Amended | $25,797,000 | $1,397,000 | Equity Only | 06b | SEC link |
| 2019-11-20 | Amended | $24,400,000 | $4,600,000 | Equity Only | 06b | SEC link |
| 2019-09-24 | Amended | $19,800,000 | $4,800,000 | Equity Only | 06b | SEC link |
| 2018-05-30 | New | $15,000,000 | $15,000,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Ani Aprahamian | Director |
| Wesley Brandt Brooksby | Director, Executive, Promoter |
| Greg Wade Brooksby | Director, Executive |
| Gregory Wade Brooksby | Director, Executive |
| Daniel Hatch | Director, Executive |
| Clyde Peter Jupiter | Director, Promoter |
| Patricia Jupiter | Director |
| Timothy W Morris | Director |
| George R Parker | Director |
| Richard G Parker | Director |
| Carl R Spiekerman | Director, Executive |
| Sheldon L Trubatch | Executive |